Comprehensive search for accessory proteins encoded with archaeal and bacterial type III CRISPR-cas gene cassettes reveals 39 new cas gene families

RNA Biology

Volumn 16, Issue 4, 2019, Pages 530-542

  Shah, Shiraz A ^a   Alkhnbashi, Omer S ^b   Behler, Juliane ^b   Han, Wenyuan ^a   She, Qunxin ^a   Hess, Wolfgang R ^b   Garrett, Roger A ^a   Backofen, Rolf ^b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

accessory; ancillary; archaea; auxillary; bacteria; CARF; cas; CRISPR; csx1; csx3; helicase; nuclease; protease; type III

Indexed keywords

ACCESSORY PROTEIN; BACTERIAL PROTEIN; CAS6 PROTEIN; HELICASE; NUCLEASE; NUCLEIC ACID; PROTEINASE; UNCLASSIFIED DRUG; CRISPR ASSOCIATED PROTEIN;

AMINO ACID SEQUENCE; ARTICLE; ASSOCIATION; CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEAT; COEVOLUTION; CONTROLLED STUDY; CRISPR CAS SYSTEM; CRYSTAL STRUCTURE; GENE CASSETTE; GENE CLUSTER; GENE DELETION; GENE SEQUENCE; GENETIC CODE; METAGENOMICS; MULTIGENE FAMILY; NONHUMAN; NORTHERN BLOTTING; PROTEIN FAMILY; SULFOLOBUS; SYNECHOCYSTIS; ARCHAEON; BACTERIUM; CHEMISTRY; CHROMOSOMAL MAPPING; GENETICS; PHYLOGENY; PROTEIN DOMAIN;

ARCHAEA; BACTERIA; CHROMOSOME MAPPING; CRISPR-ASSOCIATED PROTEINS; CRISPR-CAS SYSTEMS; GENE DELETION; MULTIGENE FAMILY; PHYLOGENY; PROTEIN DOMAINS; SYNECHOCYSTIS;

EID: 85048840591     PISSN: 15476286     EISSN: 15558584     Source Type: Journal    
DOI: 10.1080/15476286.2018.1483685     Document Type: Article

References (56)

1. Vestergaard G, Garrett RA, Shah SA., CRISPR adaptive immune systems of Archaea. RNA Biol. 2014;11:156–167.
2. Makarova KS, Wolf YI, Alkhnbashi OS, et al. An updated evolutionary classification of CRISPR-Cas systems. Nat Rev Microbiol. 2015;13:722–736.
3. Marraffini LA, Sontheimer EJ. CRISPR interference limits horizontal gene transfer in staphylococci by targeting DNA. Science. 2008;322:1843–1845.
4. Hale CR, Zhao P, Olson S, et al. RNA-guided RNA cleavage by a CRISPR RNA-Cas protein complex. Cell. 2009;139:945–956.
5. Peng W, Feng M, Feng X, et al. An archaeal CRISPR type III-B system exhibiting distinctive RNA targeting features and mediating dual RNA and DNA interference. Nucleic Acids Res. 2015;43:406–417.
6. Elmore JR, Sheppard NF, Ramia N, et al. Bipartite recognition of target RNAs activates DNA cleavage by the Type III-B CRISPR-Cas system. Genes Dev. 2016;30:447–459.
7. Zhang J, Graham S, Tello A, et al. Multiple nucleic acid cleavage modes in divergent type III CRISPR systems. Nucleic Acids Res. 2016;44:1789–1799.
8. Han W, Li Y, Deng L, et al. A type III-B CRISPR-Cas effector complex mediating massive target DNA destruction. Nucleic Acids Res. 2017;45:1983–1993.
9. Tamulaitis G, Venclovas Č, Siksnys V. Type III CRISPR-cas immunity: major differences brushed aside. Trends Microbiol. 2017;25:49–61.
10. Haft DH, Selengut J, Mongodin EF, et al. A guild of 45 CRISPR-associated (Cas) protein families and multiple CRISPR/Cas subtypes exist in prokaryotic genomes. PLoS Comput Biol. 2005;1:e60.
11. Makarova KS, Haft DH, Barrangou R, et al. Evolution and classification of the CRISPR-Cas systems. Nat Rev Microbiol. 2011;9:467–477.
12. Makarova KS, Anantharaman V, Grishin NV, et al. CARF and WYL domains: ligand-binding regulators of prokaryotic defense systems. Front Genet. 2014;5:102.
13. Zhang J, Rouillon C, Kerou M, et al. Structure and mechanism of the CMR complex for CRISPR-mediated antiviral immunity. Mol Cell. 2012;45:303–313.
14. Lintner NG, Kerou M, Brumfield SK, et al. Structural and functional characterization of an archaeal clustered regularly interspaced short palindromic repeat (CRISPR)-associated complex for antiviral defense (CASCADE). J Biol Chem. 2011;286:21643–21656.
15. Zhu X, Ye K. Crystal structure of Cmr2 suggests a nucleotide cyclase-related enzyme in type III CRISPR-Cas systems. FEBS Lett. 2012;586:939–945.
16. Deng L, Garrett RA, Shah SA, et al. A novel interference mechanism by a type IIIB CRISPR-Cmr module in Sulfolobus. Mol Microbiol. 2013;87:1088–1099.
17. Hatoum-Aslan A, Maniv I, Samai P, et al. Genetic characterization of antiplasmid immunity through a type III-A CRISPR-Cas system. J Bacteriol. 2014;196:310–317.
18. Makarova KS, Anantharaman V, Aravind L, et al. Live virus-free or die: coupling of antivirus immunity and programmed suicide or dormancy in prokaryotes. Biol Direct. 2012;7:40.
19. Kim YK, Kim Y-G, Oh B-H. Crystal structure and nucleic acid-binding activity of the CRISPR-associated protein Csx1 of Pyrococcus furiosus. Proteins. 2013;81:261–270.
20. Niewoehner O, Jinek M. Structural basis for the endoribonuclease activity of the type III-A CRISPR-associated protein Csm6. RNA. 2016;22:318–329.
21. Yan X, Guo W, Yuan YA. Crystal structures of CRISPR-associated Csx3 reveal a manganese-dependent deadenylation exoribonuclease. RNA Biol. 2015;12:749–760.
22. Topuzlu E, Lawrence CM. Recognition of a pseudo-symmetric RNA tetranucleotide by Csx3, a new member of the CRISPR associated Rossmann fold superfamily. RNA Biol. 2016;13:254–257.
23. Kazlauskiene M, Kostiuk G, Venclovas Č, et al. A cyclic oligonucleotide signaling pathway in type III CRISPR-Cas systems. Science. 2017;357:605–609.
24. Niewoehner O, Garcia-Doval C, Rostøl JT, et al. Type III CRISPR–cas systems produce cyclic oligoadenylate second messengers. Nature. 2017;548:543.
25. Han W, Pan S, López-Méndez B, et al. Allosteric regulation of Csx1, a type IIIB-associated CARF domain ribonuclease by RNAs carrying a tetraadenylate tail. Nucleic Acids Res. 2017;45:10740–10750.
26. Makarova KS, Grishin NV, Shabalina SA, et al. A putative RNA-interference-based immune system in prokaryotes: computational analysis of the predicted enzymatic machinery, functional analogies with eukaryotic RNAi, and hypothetical mechanisms of action. Biol Direct. 2006;1:7.
27. Shmakov S. Systematic prediction of genes functionally linked to CRISPR-Cas systems by gene neighborhood analysis. PNAS. 2018;115:E5307–E5316.
28. Enright AJ, Van Dongen S, Ouzounis CA. An efficient algorithm for large-scale detection of protein families. Nucleic Acids Res. 2002;30:1575–1584.
29. Punta M, Coggill PC, Eberhardt RY, et al. The Pfam protein families database. Nucleic Acids Res. 2012;40:D290–301.
30. Burley SK, Berman HM, Kleywegt GJ, et al. Protein Data Bank (PDB): the single global macromolecular structure archive. Methods Mol Biol. 2017;1607:627–641.
31. Staals RHJ, Agari Y, Maki-Yonekura S, et al. Structure and activity of the RNA-targeting Type III-B CRISPR-Cas complex of Thermus thermophilus. Mol Cell. 2013;52:135–145.
32. Benda C, Ebert J, Scheltema RA, et al. Structural model of a CRISPR RNA-silencing complex reveals the RNA-target cleavage activity in Cmr4. Mol Cell. 2014;56:43–54.
33. Hale CR, Cocozaki A, Li H, et al. Target RNA capture and cleavage by the Cmr type III-B CRISPR-Cas effector complex. Genes Dev. 2014;28:2432–2443.
34. Shah SA, Erdmann S, Mojica FJM, et al. Protospacer recognition motifs: mixed identities and functional diversity. RNA Biol. 2013;10:891–899.
35. Hein S, Scholz I, Voß B, et al. Adaptation and modification of three CRISPR loci in two closely related cyanobacteria. RNA Biol. 2013;10:852–864.
36. Scholz I, Lange SJ, Hein S, et al. CRISPR-Cas systems in the cyanobacterium Synechocystis sp. PCC6803 exhibit distinct processing pathways involving at least two Cas6 and a Cmr2 protein. PLoS One. 2013;8:e56470.
37. Reimann V, Alkhnbashi OS, Saunders SJ, et al. Structural constraints and enzymatic promiscuity in the Cas6-dependent generation of crRNAs. Nucleic Acids Res. 2017;45:915–925.
38. Behler J, Sharma K, Reimann V, et al. The host-encoded RNase E endonuclease as the crRNA maturation enzyme in a CRISPR-Cas subtype III-Bv system. Nat Rev Microbiol. 2018.
39. Lange SJ, Alkhnbashi OS, Rose D, et al. CRISPRmap: an automated classification of repeat conservation in prokaryotic adaptive immune systems. Nucleic Acids Res. 2013;41:8034–8044.
40. Alkhnbashi OS, Costa F, Shah SA, et al. CRISPRstrand: predicting repeat orientations to determine the crRNA-encoding strand at CRISPR loci. Bioinformatics. 2014;30:i489–96.
41. Alkhnbashi OS, Shah SA, Garrett RA, et al. Characterizing leader sequences of CRISPR loci. Bioinformatics. 2016;32:i576–85.
42. Bernick DL, Cox CL, Dennis PP, et al. Comparative genomic and transcriptional analyses of CRISPR systems across the genus Pyrobaculum. Front Microbiol. 2012;3:251.
43. Guo L, Brügger K, Liu C, et al. Genome analyses of Icelandic strains of Sulfolobus islandicus, model organisms for genetic and virus-host interaction studies. J Bacteriol. 2011;193:1672–1680.
44. You X-Y, Liu C, Wang S-Y, et al. Genomic analysis of Acidianus hospitalis W1 a host for studying crenarchaeal virus and plasmid life cycles. Extremophiles. 2011;15:487–497.
45. Shah SA, Garrett RA. Archaeal type II toxin-antitoxins. In: Kenn Gerdes, editor. Prokaryotic toxin-antitoxins. Berlin, Heidelberg: Springer; 2013. p. 225–238.
46. Borges AL, Davidson AR, Bondy-Denomy J. The discovery, mechanisms, and evolutionary impact of anti-CRISPRs. Annu Rev Virol. 2017;4:37–59.
47. He F, Bhoobalan-Chitty Y, Van LB, et al. Anti-CRISPR proteins encoded by archaeal lytic viruses inhibit subtype I-D immunity. Nat Microbiol. 2018;5(10):018–0120 .
48. Makarova KS, Aravind L, Grishin NV, et al. A DNA repair system specific for thermophilic Archaea and bacteria predicted by genomic context analysis. Nucleic Acids Res. 2002;30:482–496.
49. He F, Vestergaard G, Peng W, et al. CRISPR-Cas type IA Cascade complex couples viral infection surveillance to host transcriptional regulation in the dependence of Csa3b. Nucleic Acids Res. 2016;45:1902–1913.
50. Liu T, Liu Z, Ye Q, et al. Coupling transcriptional activation of CRISPR-Cas system and DNA repair genes by Csa3a in Sulfolobus islandicus. Nucleic Acids Res. 2017;45:8978–8992.
51. Sinkunas T, Gasiunas G, Fremaux C, et al. Cas3 is a single-stranded DNA nuclease and ATP-dependent helicase in the CRISPR/Cas immune system. EMBO J. 2011;30:1335–1342.
52. Beloglazova N, Petit P, Flick R, et al. Structure and activity of the Cas3 HD nuclease MJ0384, an effector enzyme of the CRISPR interference. EMBO J. 2011;30:4616–4627.
53. Westra ER, Van Erp PBG, Künne T, et al. CRISPR immunity relies on the consecutive binding and degradation of negatively supercoiled invader DNA by Cascade and Cas3. Mol Cell. 2012;46:595–605.
54. Koonin EV, Makarova KS. Discovery of oligonucleotide signaling mediated by CRISPR-associated polymerases solves two puzzles but leaves an enigma. ACS Chem Biol. 2018;13:309–312.
55. Edgar RC. MUSCLE: multiple sequence alignment with high accuracy and high throughput. Nucleic Acids Res. 2004;32:1792–1797.
56. Söding J, Biegert A, Lupas AN. The HHpred interactive server for protein homology detection and structure prediction. Nucleic Acids Res. 2005;33:W244–8.